On ECHEMI
Home > Drugs > Stable angina
Stable angina
Stable angina pectoris is the most common type of angina pectoris in clinical practice. It means that the condition is relatively stable over a long period of time (in 1979, WHO stipulated that the course of disease is stable for more than 1 month), and the frequency, duration, causes and relief of angina pectoris are relatively fixed.
  • Site of disease:

    Heart blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Weakness shortness of breath coronary artery spasm radiating pain forced standing position
  • Concurrent disease:

Related Drugs
Tirofiban Hydrochloride Injection
Indication: It is suitable for patients with unstable angina or non-Q wave myocardial infarction to prevent cardiac ischemic events. It is also suitable for patients with coronary ischemic syndrome undergoing coronary angioplasty or intracoronary plaque resection to prevent cardiac ischemic complications related to sudden occlusion of treated coronary arteries.
Tirofiban Hydrochloride for Injection
Indication: Tirofiban combined with heparin is indicated for the prevention of myocardial ischemic events in patients with unstable angina or non-Q wave myocardial infarction. It is also indicated for the prevention of cardiac ischemic complications associated with sudden occlusion of the treated coronary artery in patients with coronary ischemic syndrome undergoing coronary angioplasty or intracoronary plaque resection.
Isosorbide dinitrate and glucose injection
Indication: It is suitable for left ventricular failure secondary to acute myocardial infarction, left ventricular failure caused by various causes, and severe or unstable angina pectoris.
Manufacturer:

Heilongjiang Wusuli Jiang Pharmaceutical Co., Ltd.

Isosorbide dinitrate and glucose injection
Indication: It is suitable for left ventricular failure secondary to acute myocardial infarction, left ventricular failure caused by various causes, and severe or unstable angina pectoris.
Manufacturer:

Jinzhou Jiutai Pharmaceutical Co., Ltd.

Isosorbide dinitrate and glucose injection
Indication: It is suitable for left ventricular failure secondary to acute myocardial infarction, left ventricular failure caused by various causes, and severe or unstable angina pectoris.
Manufacturer:

Lunan BETTER Pharmaceutical Co., Ltd.

Dalteparin Sodium Injection
Indication: Treatment of acute deep vein thrombosis. Prevention of coagulation in the extracorporeal circulation system during hemodialysis and hemofiltration in patients with acute renal failure or chronic renal insufficiency. Unstable coronary heart disease, such as unstable angina and non-Q-wave myocardial infarction. Prevention of thrombosis related to surgery.
Bepridil Hydrochloride Tablets
Indication: Bepridil hydrochloride tablets are used to treat chronic stable angina pectoris (typical exertional angina pectoris). Because this product has the potential to cause fatal arrhythmias (including torsades de pointes), it is only suitable for short-term treatment (no more than one month) of refractory stable angina pectoris that is ineffective (or intolerant) to other drug treatments. This product can be administered alone or in combination with beta blockers and/or nitrates.
Manufacturer:

Changzhou Siyao Pharmaceuticals Co., Ltd.

Felodipine extended-release tablets
Indication: Hypertension (may be used alone or in combination with other antihypertensive drugs).
Manufacturer:

Nanjing Yiheng Pharmaceutical Co., Ltd.

Enalapril Maleate Tablets
Indication: Used to treat essential hypertension.
Amlodipine Besylate Tablets
Indication: 1. High direct pressure. This product is suitable for the treatment of hypertension. It can be used alone or in combination with other antihypertensive drugs. 2. Coronary heart disease (CAD), chronic stable angina. This product is suitable for the symptomatic treatment of chronic stable angina, and can be used alone or in combination with other antianginal drugs. This product is suitable for the treatment of confirmed or suspected vasospastic angina, and can be used alone or in combination with other antianginal drugs. For patients with coronary heart disease confirmed by angiography, but with an ejection fraction of 40% and no heart failure, this product can reduce the risk of hospitalization due to angina and reduce the risk of coronary artery reconstruction.
Manufacturer:

China Resources SAIKE Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.